ES2139746T3 - Heteroaril cicloalquenil hidroxiureas. - Google Patents
Heteroaril cicloalquenil hidroxiureas.Info
- Publication number
- ES2139746T3 ES2139746T3 ES94919852T ES94919852T ES2139746T3 ES 2139746 T3 ES2139746 T3 ES 2139746T3 ES 94919852 T ES94919852 T ES 94919852T ES 94919852 T ES94919852 T ES 94919852T ES 2139746 T3 ES2139746 T3 ES 2139746T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- alkyl
- chlorine
- fluorine
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052731 fluorine Inorganic materials 0.000 abstract 3
- 239000011737 fluorine Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 239000000460 chlorine Substances 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical class NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical class [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Cosmetics (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
CIERTOS NUEVOS COMPUESTOS DE HIDROXIUREA DE CICLOALQUENILO DE HETEROARILO QUE TIENEN LA CAPACIDAD DE INHIBIR LA ENZIMA 5LIPOXIGENASA Y QUE TIENEN LA FORMULA (I) Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, EN DONDE CADA R{SUP,1}, INDEPENDIENTEMENTE, ES HIDROGENO, HIDROXI, CLORO, FLUOR, ALQUILO C{SUB, 1}-C{SUB, 4}, ALCOXI C{SUB, 1}-C{SUB, 4}, HALOALQUILO C{SUB, 1}-C{SUB, 4} O HALOALCOXI C{SUB, 1}-C{SUB, 4}; R{SUP,2} ES HIDROGENO O ALQUILO C{SUB, 1}-C{SUB, 4}; R{SUP,3} ES HIDROGENO, CLORO, FLUOR O ALQUILO C{SUB, 1}-C{SUB, 4}; X ES O, S, SO O SO{SUB,2}; Z ES METILENO O ETILENO; A ES UN RADICAL DIVALENTE DERIVADO DE FURANO, TIOFENO, PIRIDINA, BENZOFURANO, BENZOTIOFENO O QUINOLINA, O UNO DE ESTOS GRUPOS QUE TIENE UN SUSTITUYENTE SELECCIONADO DE CLORO, FLUOR, ALQUILO C{SUB, 1}C{SUB, 4}, ALCOXI C{SUB, 1}-C{SUB, 4}, HALOALQUILO C{SUB, 1}C{SUB, 4} Y HALOALCOXI C{SUB, 1}-C{SUB, 4}; N ES 1, 2, O 3; Y M ES HIDROGENO O UN CATION FARMACEUTICAMENTE ACEPTABLE. ESTOS COMPUESTOS SON UTILES EN EL TRATAMIENTO O ALIVIO DE ENFERMEDADES INFLAMATORIAS, ALERGIA Y ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS Y COMO EL INGREDIENTE ACTIVO EN COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE TALES CONDICIONES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17940193 | 1993-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2139746T3 true ES2139746T3 (es) | 2000-02-16 |
Family
ID=16065226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94919852T Expired - Lifetime ES2139746T3 (es) | 1993-07-20 | 1994-07-05 | Heteroaril cicloalquenil hidroxiureas. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5665768A (es) |
EP (1) | EP0710233B1 (es) |
JP (1) | JPH08511029A (es) |
AT (1) | ATE185563T1 (es) |
CA (1) | CA2167715C (es) |
DE (1) | DE69421183T2 (es) |
DK (1) | DK0710233T3 (es) |
ES (1) | ES2139746T3 (es) |
FI (1) | FI943420L (es) |
GR (1) | GR3032238T3 (es) |
WO (1) | WO1995003292A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996016054A1 (en) * | 1994-11-18 | 1996-05-30 | Pfizer Pharmaceuticals Inc. | Cycloalkenyl-n-hydroxyureas |
AU1374601A (en) * | 1999-11-12 | 2001-05-30 | Angiotech International Ag | Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
US20030216758A1 (en) * | 2001-12-28 | 2003-11-20 | Angiotech Pharmaceuticals, Inc. | Coated surgical patches |
JP2005527302A (ja) | 2002-05-24 | 2005-09-15 | アンジオテック インターナショナル アーゲー | 医療用移植物をコーティングするための組成物および方法 |
ATE457716T1 (de) | 2002-12-30 | 2010-03-15 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1334975C (en) * | 1987-11-13 | 1995-03-28 | James H. Holms | Furan and pyrrole containing lipoxygenase inhibiting compounds |
GB9025514D0 (en) * | 1990-11-23 | 1991-01-09 | Wellcome Found | Anti-inflammatory compounds |
JP3007138B2 (ja) * | 1990-11-27 | 2000-02-07 | ファイザー製薬株式会社 | 新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物 |
JPH0717612B2 (ja) * | 1991-06-28 | 1995-03-01 | ファイザー製薬株式会社 | 新規なテトラヒドロベンズアゼピン誘導体 |
JP2989951B2 (ja) * | 1991-10-25 | 1999-12-13 | ファイザー製薬株式会社 | 新規なシクロアルキル尿素誘導体および組成物 |
US5521212A (en) * | 1991-12-13 | 1996-05-28 | Pfizer Inc. | Cyclopropyl N-hydroxyurea and N-hydroxyacetamides which inhibit lipoxygenase |
US5169854A (en) * | 1992-02-26 | 1992-12-08 | Abbott Laboratories | N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity |
US5187192A (en) * | 1992-03-13 | 1993-02-16 | Abbott Laboratories | Cyclobutyl derivatives having lipoxygenase inhibitory activity |
-
1994
- 1994-07-05 WO PCT/JP1994/001093 patent/WO1995003292A1/en active IP Right Grant
- 1994-07-05 US US08/586,833 patent/US5665768A/en not_active Expired - Fee Related
- 1994-07-05 JP JP7505049A patent/JPH08511029A/ja active Pending
- 1994-07-05 AT AT94919852T patent/ATE185563T1/de not_active IP Right Cessation
- 1994-07-05 DE DE69421183T patent/DE69421183T2/de not_active Expired - Fee Related
- 1994-07-05 ES ES94919852T patent/ES2139746T3/es not_active Expired - Lifetime
- 1994-07-05 EP EP94919852A patent/EP0710233B1/en not_active Expired - Lifetime
- 1994-07-05 DK DK94919852T patent/DK0710233T3/da active
- 1994-07-05 CA CA002167715A patent/CA2167715C/en not_active Expired - Fee Related
- 1994-07-19 FI FI943420A patent/FI943420L/fi not_active Application Discontinuation
-
1999
- 1999-12-22 GR GR990403325T patent/GR3032238T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI943420A0 (fi) | 1994-07-19 |
WO1995003292A1 (en) | 1995-02-02 |
DE69421183D1 (de) | 1999-11-18 |
FI943420L (fi) | 1995-01-21 |
DE69421183T2 (de) | 2000-01-20 |
CA2167715A1 (en) | 1995-02-02 |
ATE185563T1 (de) | 1999-10-15 |
EP0710233A1 (en) | 1996-05-08 |
EP0710233B1 (en) | 1999-10-13 |
DK0710233T3 (da) | 2000-01-03 |
GR3032238T3 (en) | 2000-04-27 |
US5665768A (en) | 1997-09-09 |
CA2167715C (en) | 1998-10-06 |
JPH08511029A (ja) | 1996-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2004003028A0 (en) | Benzamide and heteroarylamide as P2X7 receptor antagonists | |
IL152020A0 (en) | 2-alkylidene-19-nor-vitamin-d derivatives and pharmaceutical compositions containing the same | |
BR9808010B1 (pt) | Compostos de 2-alquil-19-nor-vitamina d e composição farmacêutica compreendendo os mesmos | |
DK0923581T3 (da) | 4-substituerede beta-carboliner som immunmodulatorer | |
ES2179451T3 (es) | Compuestos de 2-alquiliden-19-nor-vitamina d. | |
ES2160525B1 (es) | Derivados de la 4-aroilpiperidina antagonistas de los receptores ccr-3 | |
ES2069410T3 (es) | Nuevos derivados del acido hidroxamico y n-hidroxiurea y su uso. | |
AR023823A1 (es) | Compuestos derivados de piperazina utiles como antagonistas ccr5, composiciones farmaceuticas que los comprenden, y el uso de los mismos para la preparacion de medicamentos. | |
AR034858A1 (es) | Compuestos elevadores de abca-1,composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento | |
ES2118557T3 (es) | Compuestos de isoxazolina como inhibidores de la liberacion de tnf. | |
ES2162061T3 (es) | Derivados de piperidina como antagonistas de la neuroquinina. | |
GT200400136A (es) | Compuestos de indazol 3,5-disustituidos, composiciones farmaceuticas y metodos para intervenir en o inhibirlaproliferacion celular. | |
ES2066781T3 (es) | Nuevas n-(1-alquil-3-hidroxi-4-piperidinil)-benzamidas sustituidas. | |
ES2159717T3 (es) | Derivados de acido 5-(piperidinil-1 sustituido en posicion 4)-3-aril-pentanoico como antagonistas de los receptores de taquiquinina. | |
ES2139746T3 (es) | Heteroaril cicloalquenil hidroxiureas. | |
ES2115904T3 (es) | Derivados amino ramificados del tiazol, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen. | |
BR0008778A (pt) | Análogos de prostaglandinas seletivos para fpc16 insaturados | |
ES2109229T3 (es) | Sulfonamidas sustituidas y compuestos relacionados para el tratamiento del asma, la artritis y enfermedades relacionadas. | |
ES2121218T3 (es) | Fenoxifenilciclopentenilhidroxiureas. | |
ES2063578T3 (es) | Derivados del acido hidroxamico y de n-hidroxiurea inhibidores de la lipoxigenasa. | |
BR9909267A (pt) | C11 oximila e prostaglandinas hidroxilamino úteis como medicamentos | |
ES2138211T3 (es) | N-hidroxiureas como agentes antiinflamatorios. | |
ES2054653T3 (es) | Un procedimiento para preparar un compuesto quimico. | |
ATE167180T1 (de) | Cycloalkylhydroxyharnstoffe und ihre verwendung als lipoxy-genase-inhibitoren | |
WO2023150790A3 (en) | Novel and highly selective sars-cov-2 mpro inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 710233 Country of ref document: ES |